Then the NIH should get funding to do PSA’s on medical diagnoses and/or potential treatments. Not drug companies pushing their solutions regardless of efficacy or relevance.
I agree on the problem, my issue is the currently installed solution that is only a solution as a secondary consequence.
Then the NIH should get funding to do PSA’s on medical diagnoses and/or potential treatments. Not drug companies pushing their solutions regardless of efficacy or relevance.
I agree on the problem, my issue is the currently installed solution that is only a solution as a secondary consequence.
No disagreement here.